中美(河南)荷美尔肿瘤研究院

Breakthrough in Colon Cancer Screening

发布时间:2015-12-30
浏览次数:

E-BioMedicine, a translational medical journal co-sponsored by The Lancet and Cell, published an online paper co-authored by Dr. Kangdong Liu, Dr. Haitao Li from China- US (Henna) Hormel Cancer Institute and Dr. Yuzhou Zhao from Henan Cancer Hospital entitling “Circulating Prostaglandin Biosynthesis in Colorectal Cancer and Potential Clinical Significance”. Their research demonstrated dramatic increase of TXA A2 in patients with familial adenomatous polyposis and colon cancer and is expected to become a significant molecular biomarker for screening, prognostic judgement and treatment assessment of colon cancer. The newly-discovered detection method can be easily operated, popularized and applied among large population, which is of great significance to the early screening, prognosis and prognostic judgment of colon cancer. The paper was highly valued by celebrities in this field such as Ann C. Williams and Chris Paraskeva. They deemed the research a breakthrough and of significant application value in studying and applying prostaglandinas a biomarker for colon cancer, which should be popularized clinically.